Daniel R. Wynn,MD, FACNS, FAASM

MD, FACNS, FAASM

Neurologist, CTCA Chicago

daniel wynn
quotation

At Cancer Treatment Centers of America®, I experience unparalleled collaboration with physicians, clinicians, nurses and other clinical staff members, which ultimately benefits the patients.

Location
CTCA Chicago
Specialties
Neurology
Education
Medical school:

The Chicago Medical School, North Chicago, IL

Residency:

Neurology & Internal Medicine - Mayo Graduate School of Medicine, Rochester, MN

Fellowship:

Sleep Disorders/Polysomnography & EEG - Mayo Graduate School of Medicine

Certifications

Neurology - American Board of Psychiatry and Neurology
Clinical Neurophysiology - The American Board of Clinical Neuropsychology
EMG and Neuromuscular Disease - American Board of Electrodiagnostic Medicine
Sleep Disorders Medicine – American Board of Sleep Medicine

“I share the same passion for whole-person cancer care that Cancer Treatment Centers of America® (CTCA) embraces. It matches my personal belief about how medicine should be practiced,” says Daniel R. Wynn, MD, FACNS, FAASM, Neurologist. “Each patient works with a care team to develop a comprehensive cancer treatment plan that incorporates state-of-the-art technologies and innovative treatment options with supportive therapies.”

Dr. Wynn, who joined our hospital in Chicago in May 2016, evaluates and treats patients experiencing neurological symptoms stemming from cancer or its treatment. He works with a variety of cancer types, including brain, spine and other cancer types that spread to the brain.

“My goal is to help CTCA® patients restore both physical and spiritual wellness,” says Dr. Wynn. “Working with patients, I incorporate the advances in neurology, including the application of immunotherapy drugs, when appropriate.”

Dr. Wynn received a bachelor’s degree in biology from Reed College in Portland, Oregon, an earned a medical degree from the Chicago Medical School in Illinois. After completing residencies in internal medicine and neurology at the Mayo Graduate School of Medicine in Rochester, Minnesota, he completed fellowships at the same school in EEG and sleep disorders medicine.

Board certified in neurology, clinical neurophysiology, EMG, neuromuscular disease and sleep disorders medicine, Dr. Wynn was awarded the Melvin Leichtling Oncology Research Award. He is member of many professional organizations, including Alpha Omega Alpha Honor Medical Society, American Academy of Neurology, American Academy of Pain Medicine, American Academy of Pain Management, American Epilepsy Society, American Medical Association and American Pain Society. He is also a fellow of the American Neurophysiology Society, American Academy of Sleep Medicine and American Association of Neuromuscular and Electrodiagnostic Medicine. Dr. Wynn is a member of the Clinical Advisory Committee for the National Multiple Sclerosis Society.

Throughout Dr. Wynn’s career he has focused on research, serving as principal investigator in over 180 clinical trials, including those studying multiple sclerosis, malignant and non-malignant pain, Alzheimer’s and Parkinson’s disease, sleep disorders, stroke, headache, epilepsy, attention deficit hyperactivity disorder and others. Dr. Wynn has been widely published in The New England Journal of Medicine, Neurology, Annals of Neurology, Lancet, Lancet Neurology, Journal of Neurological Science and Journal of the American Medical Association. He has also authored journal manuscripts, book chapters and commentaries and frequently presents at national and international lectures, rounds and seminars.

Dr. Wynn currently teaches at both Chicago Medical School Rosalind Franklin University and Midwestern University Chicago College of Osteopathic Medicine. 

A Chicago native, Dr. Wynn enjoys cheering for the Chicago Bears and spending time at the Chicago Symphony Orchestra listening to classical music.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.